Infinium Pharmachem

Infinium Pharmachem

240.00
-2.00
(-0.83%)
hide
Key Fundamentals
Add Ratio
Market Cap
373.99 Cr
EPS
5.60
PE Ratio
48.11
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
337.00
52 Week Low
213.90
PB Ratio
3.45
Debt to Equity
0.38
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,781.70
#1 4,27,489.51
40.68
#1 54,729.00
9.71
#1 10,980
2.89
71.49
6,391.50
1,69,674.24
69.05
9,712.00
18.67
2,191
35.10
47.34
3,688.60
1,24,838.98
58.80
11,539.40
6.99
1,911
30.46
54.89
1,517.20
1,22,552.45
22.73
28,409.50
7.12
5,291
3.71
48.01
1,247.40
1,04,109.72
#1 18.15
33,741.20
16.73
5,725
-0.38
53.56
926.05
93,182.30
18.56
23,511.00
18.55
4,615
34.60
33.23
2,032.40
92,830.79
21.34
22,909.50
13.74
3,306
#1 72.75
58.77
2,241.80
92,532.20
52.05
12,744.20
#1 20.90
2,007
-21.05
32.96
1,209.80
70,265.38
20.70
32,345.60
9.43
3,484
3.81
63.26
5,692.50
68,062.38
28.29
13,458.30
3.70
2,216
10.98
60.35

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
15.01 %
Net Income Growth
-32.17 %
Cash Flow Change
-691.87 %
ROE
-67.12 %
ROCE
-55.70 %
EBITDA Margin (Avg.)
-19.59 %

Yearly Financial Results

Annual Financials
2022
2023
2024
2025
TTM
Revenue
100
116
137
158
0
Expenses
89
98
117
139
0
EBITDA
11
17
20
19
0
Operating Profit %
10 %
14 %
14 %
11 %
0 %
Depreciation
1
1
3
3
0
Interest
2
3
2
4
0
Profit Before Tax
9
13
15
12
0
Tax
2
3
4
4
0
Net Profit
7
10
12
8
0
EPS in ₹
60.07
6.82
10.61
5.60
0.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
59
71
86
198
Fixed Assets
4
19
20
24
Current Assets
44
51
65
140
Capital Work in Progress
9
0
0
1
Investments
0
0
0
29
Other Assets
46
52
66
144
Total Liabilities
59
71
86
198
Current Liabilities
32
37
17
64
Non Current Liabilities
14
10
8
10
Total Equity
14
24
60
125
Reserve & Surplus
12
18
45
94
Share Capital
1
5
14
16

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
1
4
1
6
23
Investing Activities
-1
-5
-7
-5
-4
-27
Operating Activities
3
7
12
9
5
-29
Financing Activities
-1
-1
-2
-3
5
79

Share Holding

% Holding
Feb 2023
Mar 2023
Apr 2023
Sept 2023
Mar 2024
Sept 2024
Nov 2024
Mar 2025
Sept 2025
Promoter
100.00 %
100.00 %
73.05 %
73.05 %
73.05 %
73.05 %
65.24 %
65.24 %
59.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
22.56 %
23.96 %
23.85 %
23.97 %
32.05 %
32.00 %
37.21 %
Others
0.00 %
0.00 %
4.38 %
2.99 %
3.10 %
2.98 %
2.71 %
2.76 %
2.88 %
No of Share Holders
17
17
1,145
646
771
947
998
958
1,052

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Sept 2023 BONUS Bonus
1:1
13 Sept 2023 500.55 495.00
06 Jul 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
06 Jul 2024 223.00 229.20
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 195.85 336.00
23 Oct 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
23 Oct 2024 336.00 308.75
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 321.25 328.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 280.60 316.25
21 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Aug 2025 252.25 267.50
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 264.00 260.60

Technical Indicators

RSI(14)
Neutral
39.93
ATR(14)
Volatile
8.61
STOCH(9,6)
Oversold
9.86
STOCH RSI(14)
Oversold
19.69
MACD(12,26)
Bearish
-2.35
ADX(14)
Weak Trend
12.12
UO(9)
Bullish
26.24
ROC(12)
Downtrend And Accelerating
-8.33
WillR(14)
Oversold
-93.32